NNOX earnings

Advanced commercialization in the US, signing multiple new customer and distribution agreements for Nanox.ARC and accelerated activities around Nanox.AI Management to host conference call and webcast Monday, April 20, 2026 at 8:30 AM ET Appointed new CFO effective August 1, 2026 PETAH TIKVA, Israel, April 20, 2026 (GLOBE NEWSWIRE) -- NANO-X IMAGING LTD (NASDAQ:NNOX) ("Nanox" or the "Company"), an innovative medical imaging technology company, today announced results for the fourth quarter ended December 31, 2025, and provided a business update. Recent Highlights: Generated $3.7 million in revenue in the fourth quarter of 2025, compared to $3.0 million in the fourth quarter o

PETACH TIKVA, Israel, April 06, 2026 (GLOBE NEWSWIRE) -- NANO-X IMAGING LTD ((", Nanox", or the ", Company", , NASDAQ:NNOX), an innovative medical imaging technology company, today announced that it will report its financial results for the quarter ended December 31, 2025, before market open on Monday, April 20, 2026. Erez Meltzer, Chief Executive Officer and Acting Chairman, and Ran Daniel, Chief Financial Officer, will host a conference call to review these results and provide a business update beginning at 8:30 a.m. ET. Interested parties may register for the conference call using the following link: Nanox Q4 2025 Call The live webcast of the conference call may be accessed by using t

Management to host conference call and webcast Thursday, November 20, 2025, at 8:30 AM ET Company advances commercialization and is on track to meet year-end system deployment target PETAH TIKVA, Israel, Nov. 20, 2025 (GLOBE NEWSWIRE) -- NANO-X IMAGING LTD (NASDAQ:NNOX) ("Nanox" or the "Company"), an innovative medical imaging technology company, today announced results for the third quarter ended September 30, 2025, and provided a business update. Recent Highlights: Generated $3.4 million in revenue in the third quarter of 2025, compared to $3.0 million in the third quarter of 2024.Acquired 100% of the stock of Vaso Healthcare IT, a provider of healthcare information technologies solu

PETACH TIKVA, Israel, Nov. 07, 2025 (GLOBE NEWSWIRE) -- NANO-X IMAGING LTD ((", Nanox", or the ", Company", , NASDAQ:NNOX), an innovative medical imaging technology company, today announced that it will report its financial results for the quarter ended September 30, 2025, before market open on Thursday, November 20, 2025. Erez Meltzer, Chief Executive Officer and Acting Chairman, and Ran Daniel, Chief Financial Officer, will host a conference call to review these results and provide a business update beginning at 8:30 a.m. ET. Interested parties may register for the conference call using the following link:  Nanox Q3 2025 Conference Call. The live webcast of the conference call may be ac

Management to host conference call and webcast Tuesday, August 12, 2025 at 8:30 AM ET Company continued to grow Nanox.ARC installed base and is on track to meet its year-end system deployment target PETAH TIKVA, Israel, Aug. 12, 2025 (GLOBE NEWSWIRE) -- NANO-X IMAGING LTD (NASDAQ:NNOX) ("Nanox" or the "Company"), an innovative medical imaging technology company, today announced results for the second quarter ended June 30, 2025 and provided a business update. Recent Highlights: Generated $3.0 million in revenue in the second quarter of 2025, compared to $2.7 million in the second quarter of 2024.Grew Nanox.ARC system sales funnel exponentially in the quarter.The Company notified the FD

PETACH TIKVA, Israel, Aug. 01, 2025 (GLOBE NEWSWIRE) -- NANO-X IMAGING LTD ((", Nanox", or the ", Company", , NASDAQ:NNOX), an innovative medical imaging technology company, today announced that it will report its financial results for the quarter ended June 30, 2025, before market open on Tuesday, August 12, 2025. Erez Meltzer, Chief Executive Officer and Acting Chairman, and Ran Daniel, Chief Financial Officer, will host a conference call to review these results and provide a business update beginning at 8:30 a.m. ET. Interested parties may register for the conference call using the following link: Nanox Q2 2025 Conference Call. The live webcast of the conference call may be accessed by

PETACH TIKVA, Israel, May 22, 2025 (GLOBE NEWSWIRE) -- NANO-X IMAGING LTD (NASDAQ:NNOX) ("Nanox" or the "Company"), an innovative medical imaging technology company, today announced results for the first quarter ended March 31, 2025, and provided a business update. Recent Highlights: Generated $2.8 million in revenue in the first quarter of 2025, compared to $2.6 million in the first quarter of 2024.Received 510(k) clearance from the FDA for the Nanox.ARC X, its updated multi-source digital Tomosynthesis system.Signed multiple commercial agreements to market the Nanox.ARC and the Nanox.AI solutions. "Since the beginning of 2025, Nanox has made consistent progress marketing our full end-

PETACH TIKVA, Israel, May 08, 2025 (GLOBE NEWSWIRE) -- NANO-X IMAGING LTD ((", Nanox", or the ", Company", , NASDAQ:NNOX), an innovative medical imaging technology company, today announced that it will report its financial results for the quarter ended March 31, 2025, before market open on Thursday, May 22, 2025. Erez Meltzer, Chief Executive Officer and Acting Chairman, and Ran Daniel, Chief Financial Officer, will host a conference call to review these results and provide a business update beginning at 8:30 a.m. ET. Interested parties may register for the conference call using the following link: Nanox Q1 2025 Earnings Call Registration. The live webcast of the conference call may be

PETACH TIKVA, Israel, March 17, 2025 (GLOBE NEWSWIRE) -- NANO-X IMAGING LTD ((", Nanox", or the ", Company", , NASDAQ:NNOX), an innovative medical imaging technology company, today announced that it will report its financial results for the quarter and fiscal year ended December 31, 2024, before market open on Monday, March 31, 2025. Erez Meltzer, Chief Executive Officer and Acting Chairman, and Ran Daniel, Chief Financial Officer, will host a conference call to review these results and provide a business update beginning at 8:30 a.m. ET. Interested parties may register for the conference call using the following link: Nanox Q4 Earnings Call Registration. The live webcast of the conferenc

Made progress deploying all components of the Nanox solution including Nanox.ARC and Nanox.AI Expanded US sales and support staff a key component of global strategic growth plan Management to host conference call and webcast Thursday, November 21, 2024 at 8:30 AM ET PETACH TIKVA, Israel, Nov. 21, 2024 (GLOBE NEWSWIRE) -- November 21, 2024 — NANO-X IMAGING LTD (NASDAQ:NNOX) ("Nanox" or the "Company"), an innovative medical imaging technology company, today announced results for the third quarter ended September 30, 2024 and provided a business update. Recent Highlights: Generated $3.0 million in revenue in the third quarter of 2024, compared to $2.5 million in the third quarter of 2023

PETACH TIKVA, Israel, Nov. 11, 2024 (GLOBE NEWSWIRE) -- NANO-X IMAGING LTD (("Nanox" or the "Company, NASDAQ:NNOX), an innovative medical imaging technology company, today announced that it will report its financial results for the quarter ended September 30, 2024, before market open on Thursday, November 21, 2024. Erez Meltzer, Chief Executive Officer and Acting Chairman, and Ran Daniel, Chief Financial Officer, will host a conference call to review these results and provide a business update beginning at 8:30 a.m. ET. Interested parties may register for the conference call using the following link: Nanox Q3 Earnings Call Registration. You may access the live webcast of the conference ca

PETACH TIKVA, Israel, Aug. 06, 2024 (GLOBE NEWSWIRE) -- NANO-X IMAGING LTD (("Nanox" or the "Company, NASDAQ:NNOX), an innovative medical imaging technology company, today announced that it will report its financial results for the quarter ended June 30, 2024, before market open on Tuesday, August 20, 2024. Erez Meltzer, Chief Executive Officer and Acting Chairman, and Ran Daniel, Chief Financial Officer, will host a conference call to review these results and provide a business update beginning at 8:30 a.m. ET. Interested parties may register for the conference call using the following link:  Nanox Q2 Earnings Call Registration. You may access the live webcast of the conference call by u

PETACH TIKVA, Israel, May 20, 2024 (GLOBE NEWSWIRE) -- NANO-X IMAGING LTD (("Nanox" or the "Company, NASDAQ:NNOX), an innovative medical imaging technology company, today announced that it will report its financial results for the quarter ended March 31, 2024, before market open on Tuesday, May 28, 2024. Erez Meltzer, Chief Executive Officer, and Ran Daniel, Chief Financial Officer, will host a conference call to review these results and provide a business update beginning at 8:30 a.m. ET. Interested parties may register for the conference call using the following link:  Nanox Q1 Earnings Call Registration. You may access the live webcast of the conference call by using the following link

PETAH TIKVA, Israel, March 18, 2024 (GLOBE NEWSWIRE) -- NANO-X IMAGING LTD (NASDAQ:NNOX) ("Nanox" or the "Company"), an innovative medical imaging technology company, today announced that it will report its financial results for the quarter and fiscal year ended December 31, 2023, before market open on Monday, April 1, 2024. Erez Meltzer, Chief Executive Officer, and Ran Daniel, Chief Financial Officer, will host a conference call to review these results and provide a business update beginning at 8:30 a.m. ET. Interested parties may register for the conference call using the following link:  Nanox Q4 Earnings Call Registration. You may access the live webcast of the conference call by usi

NEVE ILAN, Israel, Nov. 09, 2023 (GLOBE NEWSWIRE) -- NANO-X IMAGING LTD (NASDAQ:NNOX) ("Nanox" or the "Company"), an innovative medical imaging technology company, today announced that it will report its financial results for the quarter ended September 30, 2023 on November 28, 2023 at 8:30 a.m. ET. The Company also announced that it will hold its Investor Day on December 4, 2023, at the Nasdaq building in New York City. Earnings Call Information Interested parties may register for the conference call using the following link: https://register.vevent.com/register/BI7080cf9036fa460db045f1becd1a1cf1 You may access the live webcast of the conference call by using the following link: https:

NEVE ILAN, Israel, May 17, 2023 (GLOBE NEWSWIRE) -- NANO-X IMAGING LTD ((", Nanox", or the ", Company, ", NASDAQ:NNOX) will report its financial results for the first quarter ended March 31, 2023 before market on Monday, May 22, 2023. Erez Meltzer, Chief Executive Officer, and Ran Daniel, Chief Financial Officer, will host a conference call to review these results and provide a business update beginning at 8:30 a.m. ET. Interested parties may register for the conference call using the following link: Nanox Q1 2023 Earnings Registration Link. You may access the live webcast of the conference call by using the following link: Nanox Q1 2023 Earnings. Both links will be posted in the Investor

NANO-X IMAGING LTD ((", Nanox", or the ", Company, ", NASDAQ:NNOX) will report its financial results for the fourth quarter ended December 31, 2022 before market on Thursday, March 9, 2023. Erez Meltzer, Chief Executive Officer, and Ran Daniel, Chief Financial Officer, will host a conference call to review these results and provide a business update beginning at 8:30 a.m. ET. Interested parties may register for the conference call using the following link: Nanox Q4 2022 Earnings Registration Link. You may access the live webcast of the conference call by using the following link: Nanox Q4 2022 Earnings. The link will also be posted in the Investor Relations section of the Nanox website at

Reports progress towards global supply chain development Ended the third quarter of 2022 with cash, cash equivalents and marketable securities of $117.1 million Management to host conference call and webcast Thursday, November 10, 2022 at 8:30 AM ET NEVE ILAN, Israel, Nov. 10, 2022 (GLOBE NEWSWIRE) -- NANO-X IMAGING LTD (NASDAQ:NNOX) ("Nanox" or the "Company"), an innovative medical imaging technology company, today announced results for the third quarter ended September 30, 2022 and provided a business update. Third Quarter 2022 Highlights and Recent Developments: Generated $2.4 million in revenue in the third quarter of 2022 compared to $2.2 million in the second quarter of 2022 and

NEVE ILAN, Israel, Oct. 31, 2022 (GLOBE NEWSWIRE) -- NANO-X IMAGING LTD ((", Nanox", or the ", Company, ", NASDAQ:NNOX) will report its financial results for the third quarter ended September 30, 2022 before market on Thursday, November 10, 2022. Erez Meltzer, Chief Executive Officer, and Ran Daniel, Chief Financial Officer, will host a conference call to review these results and provide a business update beginning at 8:30 a.m. ET. Interested parties may register for the conference call using the following link: Nanox Q3 2022 Earnings Registration Link. You may access the live webcast of the conference call by using the following link: Nanox Q2 2022 Earnings. The link will also be p

Reports progress towards global supply chain development Ended the second quarter of 2022 with cash, cash equivalents and marketable securities of $126.7 million Management to host conference call and webcast today, August 16, 2022 at 8:30 AM ET NANO-X IMAGING LTD (NASDAQ:NNOX) ("Nanox" or the "Company"), an innovative medical imaging technology company, today announced results for the second quarter ended June 30, 2022 and provided a business update. Second Quarter 2022 Highlights and Recent Developments: Generated $2.2 million in revenue in the second quarter of 2022 compared to $1.8 million in the first quarter of 2022. The Company was added to the Russell 2000® and Russell 3000®

NANO-X IMAGING LTD ((", Nanox", or the ", Company, ", NASDAQ:NNOX) will report its financial results for the second quarter ended June 30, 2022 before market on Tuesday, August 16, 2022. Erez Meltzer, Chief Executive Officer, and Ran Daniel, Chief Financial Officer, will host a conference call to review these results and provide a business update beginning at 8:30 a.m. ET. Interested parties may register for the conference call using the following link: Nanox Q2 2022 Earnings Registration Link. You may access the live webcast of the conference call by using the following link: Nanox Q2 2022 Earnings. The link will also be posted in the Investor Relations section of the Nanox website at Eve

Reports progress towards global supply chain development Ended the first quarter of 2022 with cash and marketable securities of $139.5 million Management to host conference call and webcast today, May 19, 2022 at 8:30 AM ET NANO-X IMAGING LTD (NASDAQ:NNOX) ("Nanox" or the "Company"), an innovative medical imaging technology company, today announced results for the first quarter ended March 31, 2022 and provided a business update. First Quarter Highlights and Recent Developments: Generated $1.8 million in revenues in the quarter, compared to no revenue in the first quarter of 2021, and a 38% increase from $1.3 million in the fourth quarter of 2021. Reported accelerated growth in the

NANO-X IMAGING LTD ((", Nanox", or the ", Company, ", NASDAQ:NNOX) will report its results for the first quarter ended March 31, 2022 before market on Thursday, May 19, 2022. Erez Meltzer, Chief Executive Officer, and Ran Daniel, Chief Financial Officer, will host a conference call to review these results and provide a business update beginning at 8:30 a.m. ET. Interested parties may access the conference call by dialing (877) 550-3765 (Domestic) or (409) 937-8962 (International) and reference Access Code 8476729. Participants wishing to join the call via webcast may use the following webcast link: Nanox Q1 2022 Earnings. The link will also be posted in the Investor Relations section of th

Management to host conference call and webcast today, March 31, at 8:30 AM ET NANO-X IMAGING LTD (NASDAQ:NNOX) ("Nanox" or the "Company"), an innovative medical imaging technology company, today announced results for the fourth quarter ended December 31, 2021 and provided a business update. Fourth Quarter Highlights and Recent Developments: Revenue for the fourth quarter of 2021 was $1.3M and non-GAAP gross profit was $0.2 million Strengthened leadership positions with the appointments of Erez Meltzer as Chief Executive Officer of the Company and Pini Ben Elazar as General Manager of Nanox.AI Our subsidiary, USARAD, was recertified with the Joint Commission's Gold Seal of Approval

NANO-X IMAGING LTD ("Nanox" or the "Company," Nasdaq: NNOX) will report its results for the fourth quarter and full year ended December 31, 2021 before market on Thursday, March 31, 2022. Erez Meltzer, Chief Executive Officer, and Ran Daniel, Chief Financial Officer, will host a conference call to review these results and provide a business update beginning at 8:30 a.m. ET. Interested parties may access the conference call by dialing (877) 550-3765 (Domestic) or (409) 937-8962 (International) and reference Access Code 5583017. Participants wishing to join the call via webcast may use the following webcast link: Nanox Q4 2021 Earnings. The link will also be posted in the Investor Relations

Reports progress towards global supply chain development Ended the third quarter with cash and marketable securities of $180.3 million Management to host conference call and webcast today, November 17, at 8:30 AM ET NANO-X IMAGING LTD (NASDAQ:NNOX) ("Nanox" or the "Company"), an innovative medical imaging technology company, today announced results for the third quarter ended September 30, 2021 and provided a business update. As previously reported, Nanox completed the merger with NANO-X AI LTD (formerly Zebra Medical Vision LTD, "Nanox AI"), a deep-learning medical imaging analytics company, in an all-stock deal valued at approximately $110 million at closing, with up to $84 million i

NANO-X IMAGING LTD ("Nanox" or the "Company," Nasdaq: NNOX) will report its results for the third quarter ended September 30, 2021 before market on Wednesday, November 17, 2021. Ran Poliakine, Chairman and Chief Executive Officer, and Erez Meltzer, Director (appointed CEO effective January 1, 2022), will host a conference call to review these results and provide a business update beginning at 8:30 a.m. ET. Interested parties may access the conference call by dialing (877) 550-3765 (Domestic) or (409) 937-8962 (International) and reference Access Code 7872065. Participants wishing to join the call via webcast should use the link posted on the investor relations section of the Nanox website

NEVE ILAN, Israel, July 27, 2021 (GLOBE NEWSWIRE) -- NANO-X IMAGING LTD (NASDAQ:NNOX) ("Nanox" or the "Company"), an innovative medical imaging technology company, announces that it will release its second quarter 2021 financial and operating results for the period ended June 30, 2021 on Tuesday, August 10, 2021 prior to the start of trading. Management will host a conference call and webcast at 8:30am ET on that day. Conference call and webcast details Tuesday, August 10, 2021 @ 8:30am ETInvestor domestic dial-in:   855-327-6837Investor international dial-in:   631-891-4304Conference ID: 10015901Webcast link: http://public.viavid.com/index.php?id=146006 About Nanox: Nanox, founded by t